WO2000007627A8 - Topical delivery systems for active agents - Google Patents
Topical delivery systems for active agentsInfo
- Publication number
- WO2000007627A8 WO2000007627A8 PCT/US1999/017387 US9917387W WO0007627A8 WO 2000007627 A8 WO2000007627 A8 WO 2000007627A8 US 9917387 W US9917387 W US 9917387W WO 0007627 A8 WO0007627 A8 WO 0007627A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- agents
- active agents
- delivery systems
- topical delivery
- hair
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0291—Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
- A61K8/355—Quinones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/731—Cellulose; Quaternized cellulose derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/90—Block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/006—Antidandruff preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
- A61Q7/02—Preparations for inhibiting or slowing hair growth
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU56695/99A AU5669599A (en) | 1998-08-04 | 1999-08-02 | Topical delivery systems for active agents |
JP2000563309A JP2003521452A (en) | 1998-08-04 | 1999-08-02 | Local delivery system for active agents |
CA002339231A CA2339231A1 (en) | 1998-08-04 | 1999-08-02 | Topical delivery systems for active agents |
EP99943639A EP1104280A2 (en) | 1998-08-04 | 1999-08-02 | Topical delivery systems for active agents |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9528998P | 1998-08-04 | 1998-08-04 | |
US60/095,289 | 1998-08-04 | ||
US09/360,412 | 1999-07-23 | ||
US09/360,412 US6284234B1 (en) | 1998-08-04 | 1999-07-23 | Topical delivery systems for active agents |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2000007627A2 WO2000007627A2 (en) | 2000-02-17 |
WO2000007627A3 WO2000007627A3 (en) | 2000-08-17 |
WO2000007627A8 true WO2000007627A8 (en) | 2001-02-08 |
Family
ID=26790038
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/017387 WO2000007627A2 (en) | 1998-08-04 | 1999-08-02 | Topical delivery systems for active agents |
Country Status (10)
Country | Link |
---|---|
US (2) | US6284234B1 (en) |
EP (1) | EP1104280A2 (en) |
JP (1) | JP2003521452A (en) |
CN (1) | CN1303263A (en) |
AR (1) | AR019997A1 (en) |
AU (1) | AU5669599A (en) |
CA (1) | CA2339231A1 (en) |
CO (1) | CO5080786A1 (en) |
TW (1) | TWI257310B (en) |
WO (1) | WO2000007627A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE43372E1 (en) | 1999-03-05 | 2012-05-08 | Duke University | C16 unsaturated FP-selective prostaglandins analogs |
US8906962B2 (en) | 2000-03-31 | 2014-12-09 | Duke University | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
US9006291B2 (en) | 2009-02-03 | 2015-04-14 | Pharma Patent Holding Inc. | Composition, method and kit for enhancing hair |
US9346837B2 (en) | 2000-03-31 | 2016-05-24 | Duke University | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
Families Citing this family (212)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7011834B1 (en) * | 1987-01-30 | 2006-03-14 | The Board Of Trustees Of Leland Stanford Junior University | Immunomodulating dimers |
GB9504265D0 (en) * | 1995-03-03 | 1995-04-19 | Medeva Plc | Corticosteroid-containing pharmaceutical composition |
US6512010B1 (en) * | 1996-07-15 | 2003-01-28 | Alza Corporation | Formulations for the administration of fluoxetine |
AUPO983897A0 (en) | 1997-10-17 | 1997-11-06 | Soltec Research Pty Ltd | Topical antifungal composition |
AUPP310798A0 (en) | 1998-04-22 | 1998-05-14 | Soltec Research Pty Ltd | Vehicle system for a composition comprising a piperidinopyrimidine derivative |
DE19921794A1 (en) * | 1999-05-11 | 2000-11-23 | Hexal Ag | New pharmaceutical composition |
CA2309373A1 (en) * | 1999-05-27 | 2000-11-27 | Johnson & Johnson Consumer Companies, Inc. | Novel topical formulations |
US6762158B2 (en) * | 1999-07-01 | 2004-07-13 | Johnson & Johnson Consumer Companies, Inc. | Personal care compositions comprising liquid ester mixtures |
IL132625A (en) * | 1999-10-28 | 2007-06-17 | Avi Dascalu | Composition for inducing hair growth |
US20090098065A1 (en) * | 2000-01-11 | 2009-04-16 | Avikam Harel | Composition and methods for the treatment of skin disorders |
US6596266B2 (en) * | 2000-02-18 | 2003-07-22 | Natural Science, Inc. | Compositions containing minoxidil and saw palmetto for treating baldness |
JP4213837B2 (en) * | 2000-02-18 | 2009-01-21 | 株式会社マンダム | Hair restorer composition |
US20020037914A1 (en) * | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
KR100867052B1 (en) * | 2000-04-07 | 2008-11-04 | 다이쇼 세이야꾸 가부시끼가이샤 | Hair Growth Stimulant Compositions with Sustained Action |
NZ504526A (en) * | 2000-05-12 | 2003-05-30 | Meracol Corp Ltd | Treating herpes simplex symptoms using a mixture of cetyl myristate and cetyl palmitate |
WO2001085162A1 (en) * | 2000-05-12 | 2001-11-15 | Meracol Corporation Limited | Treating irritable bowel syndrome or disease |
US20030153620A1 (en) | 2000-05-12 | 2003-08-14 | Meakin Timothy David | Treating eczema and/or psoriasis |
AU6083301A (en) * | 2000-05-12 | 2001-11-20 | Meracol Corp Ltd | Treating eczema and/or psoriasis |
US20050008602A1 (en) * | 2000-06-05 | 2005-01-13 | Sumitomo Electric Industries, Ltd. | Oligopeptides for promoting hair growth |
US7241731B2 (en) | 2000-06-05 | 2007-07-10 | Sumitomo Electric Industries, Ltd. | Oligopeptides for promoting hair growth |
AUPQ875700A0 (en) * | 2000-07-13 | 2000-08-03 | Reflex Research Limited | Combination compositions |
FR2812191B1 (en) * | 2000-07-28 | 2003-10-17 | Oreal | USE OF PROSTAGLANDIN E2 RECEPTOR AGONISTS (EP-3) TO ATTENUATE, DECREASE OR STOP HAIR AND HAIR GROWTH IN COSMETIC PREPARATIONS |
FR2812192B1 (en) * | 2000-07-28 | 2003-01-31 | Oreal | USE OF PROSTAGLANDIN EP-3 RECEPTOR ANTAGONISTS AS A COSMETIC AGENT FOR MITIGATING, REDUCING OR STOPPING HAIR AND HAIR LOSS |
FR2812193B1 (en) * | 2000-07-28 | 2003-10-24 | Oreal | USE OF AN ANTAGONIST OF PROSTAGLANDIN EP-2 AND / OR EP-4 RECEPTORS TO ATTENUATE, DECREASE OR STOP HAIR AND HAIR GROWTH IN COSMETIC PREPARATIONS |
FR2812190B1 (en) * | 2000-07-28 | 2003-01-31 | Oreal | USE OF NON-PROSTANOIC AGONISTS OF EP-2 AND / OR EP-4 PROSTAGLANDIN RECEPTORS AS A COSMETIC AGENT FOR MITIGATING, DECREASING OR STOPPING HAIR AND HAIR LOSS |
US20040198706A1 (en) * | 2003-03-11 | 2004-10-07 | Carrara Dario Norberto R. | Methods and formulations for transdermal or transmucosal application of active agents |
EP1307232B1 (en) | 2000-08-03 | 2007-03-07 | Antares Pharma IPL AG | Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels |
US8980290B2 (en) | 2000-08-03 | 2015-03-17 | Antares Pharma Ipl Ag | Transdermal compositions for anticholinergic agents |
US7198801B2 (en) * | 2000-08-03 | 2007-04-03 | Antares Pharma Ipl Ag | Formulations for transdermal or transmucosal application |
US7442369B1 (en) * | 2000-08-09 | 2008-10-28 | Mcneil Ab | Compositions of minoxidil |
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
US20040092494A9 (en) * | 2000-08-30 | 2004-05-13 | Dudley Robert E. | Method of increasing testosterone and related steroid concentrations in women |
WO2002019972A2 (en) * | 2000-09-08 | 2002-03-14 | Vivier Canada Inc. | Stabilized ascorbic acid solutions |
US6562321B2 (en) * | 2000-12-20 | 2003-05-13 | Avon Products, Inc. | Compositions and methods for treating hyperpigmentation |
US20040067245A1 (en) * | 2000-12-20 | 2004-04-08 | Harish Mahalingam | Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin |
KR100423666B1 (en) * | 2001-02-07 | 2004-03-18 | 보령제약 주식회사 | Composition of Antifungal Topical preparations |
JP2003012468A (en) * | 2001-06-28 | 2003-01-15 | Kaminomoto Co Ltd | Promoter for restoration and growth of hair |
WO2003007901A1 (en) * | 2001-07-18 | 2003-01-30 | Unilever Plc | Hair and/or scalp treatment compositions |
US6866841B2 (en) | 2001-08-09 | 2005-03-15 | Epatentmanager.Com | Non-endocrine disrupting cytoprotective UV radiation resistant substance |
US7261878B2 (en) * | 2001-08-10 | 2007-08-28 | The Gillette Company | Reduction of hair growth |
US20030036561A1 (en) * | 2001-08-10 | 2003-02-20 | Peter Styczynski | Reduction of hair growth |
US20070238697A1 (en) * | 2001-08-29 | 2007-10-11 | University Of British Columbia | Pharmaceutical compositions and methods relating to fucans |
DE60224335T2 (en) * | 2001-09-28 | 2008-12-11 | Nof Corp. | Skin treatment composition |
JP2003113023A (en) * | 2001-09-28 | 2003-04-18 | Shiseido Co Ltd | Base for skin care preparation and cosmetic formulated with the same |
EP1435899B1 (en) * | 2001-09-28 | 2009-03-11 | LG Household & Health Care Ltd. | A composition for promoting hair growth |
SE0104421D0 (en) | 2001-12-21 | 2001-12-21 | Ponsus Pharma Ab | New composition |
US7160921B2 (en) * | 2002-01-29 | 2007-01-09 | The Gillette Company | Reduction of hair growth |
US20040198821A1 (en) * | 2002-01-29 | 2004-10-07 | Hwang Cheng Shine | Reduction of hair growth |
US20030199584A1 (en) * | 2002-04-11 | 2003-10-23 | Ahluwalia Gurpreet S. | Reduction of hair growth |
US7241808B2 (en) * | 2002-05-01 | 2007-07-10 | Marvin Klein | Composition for treatment of skin and method for stabilizing the composition |
US20030232091A1 (en) * | 2002-06-17 | 2003-12-18 | Adi Shefer | Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof |
SI21258A (en) * | 2002-07-17 | 2004-02-29 | LEK farmacevtska dru�ba d.d. | Stable pharmaceutical preparation containing erythropoietin and poloxamer polyol |
DE10240029A1 (en) * | 2002-08-27 | 2004-03-11 | Beiersdorf Ag | Synergistic antimycotic combinations of climbazole, piroctone olamine and undecyleneamidopropyl betaine, useful for combating seborrheic disorders, especially dandruff |
US8900607B1 (en) | 2002-09-25 | 2014-12-02 | Chemsil Silicones, Inc. | Clear, greaseless skin-care compositions |
US20040086471A1 (en) * | 2002-10-31 | 2004-05-06 | Lin Connie Baozhen | Compositions for darkening the skin and/or hair |
US7939489B2 (en) * | 2002-12-23 | 2011-05-10 | Avon Products, Inc. | Oil absorbent topical compositions and methods for using same |
US20040141935A1 (en) * | 2003-01-21 | 2004-07-22 | Peter Styczynski | Reduction of hair growth |
ES2450133T3 (en) * | 2003-01-24 | 2014-03-24 | Stiefel Research Australia Pty Ltd | Clindamycin Phosphate Foam |
EP1594484A2 (en) * | 2003-02-17 | 2005-11-16 | Cipla Ltd. | Pharmaceutical patch |
US7015349B2 (en) | 2003-03-26 | 2006-03-21 | The Gillette Company | Reduction of hair growth |
US7186416B2 (en) * | 2003-05-28 | 2007-03-06 | Stiefel Laboratories, Inc. | Foamable pharmaceutical compositions and methods for treating a disorder |
US20050037046A1 (en) * | 2003-07-31 | 2005-02-17 | Ken Braun | Fish attractant and applicator |
EP1663127B2 (en) * | 2003-09-10 | 2017-02-15 | The Procter & Gamble Company | Skin care composition |
MXPA06003316A (en) | 2003-10-10 | 2006-06-08 | Antares Pharma Ipl Ag | Transdermal pharmaceutical formulation for minimizing skin residues. |
US20050095215A1 (en) * | 2003-11-03 | 2005-05-05 | Popp Karl F. | Antimicrobial shampoo compositions |
US20050112075A1 (en) * | 2003-11-25 | 2005-05-26 | Hwang Cheng S. | Reduction of hair growth |
FR2863174B1 (en) * | 2003-12-08 | 2006-11-24 | Galderma Res & Dev | DEVICE FOR DETERMINING A PRODUCT INTENDED TO BE APPLIED ON THE SKIN |
US20050132466A1 (en) * | 2003-12-11 | 2005-06-23 | Kimberly-Clark Worldwide, Inc. | Elastomeric glove coating |
US20050127552A1 (en) | 2003-12-11 | 2005-06-16 | Kimberly-Clark Worldwide, Inc. | Method for forming an elastomeric article |
US7935331B2 (en) * | 2003-12-12 | 2011-05-03 | Johnson & Johnson Consumer Companies, Inc. | Vanillin polymers for use in darkening the skin |
US20050136015A1 (en) * | 2003-12-17 | 2005-06-23 | McKie Derrick B. | Topical use of halosalicylic acid derivatives |
US20070086977A1 (en) * | 2003-12-22 | 2007-04-19 | Stockel Richard F | Method of treating dermatological conditions |
DE102004063927A1 (en) * | 2004-01-23 | 2005-12-15 | Epoplus Gmbh Co.Kg | Use of low dose erythropoietin to stimulate endothelial progenitor cells as well as organ regeneration and progression slowing of end organ damage |
US20050163811A1 (en) * | 2004-01-23 | 2005-07-28 | Richard Lee | Topical solutions comprising high concentrations of piperidinopyrimidine derivatives and methods of use thereof |
US20050196371A1 (en) * | 2004-03-08 | 2005-09-08 | L'oreal | Aqueous composition based on alcohol, surfactant and solubilizing agent, article impregnated with this composition, and method for cleansing the hair |
US20050249685A1 (en) * | 2004-04-27 | 2005-11-10 | Natalia Botchkareva | Reduction of hair growth |
US7425340B2 (en) * | 2004-05-07 | 2008-09-16 | Antares Pharma Ipl Ag | Permeation enhancing compositions for anticholinergic agents |
US8158139B2 (en) * | 2004-07-12 | 2012-04-17 | Taro Pharmaceuticals North America, Inc. | Topical gel formulation comprising organophosphate insecticide and preparation thereof |
WO2006017263A1 (en) * | 2004-07-12 | 2006-02-16 | Taro Pharmaceutical Industries Ltd. | Topical gel formulation comprising organophosphate insecticide and its preparation thereof |
WO2006017232A1 (en) * | 2004-07-12 | 2006-02-16 | Taro Pharmaceuticals Industries Ltd. | Topical gel formulation comprising insecticide and its preparation thereof |
US20060018861A1 (en) * | 2004-07-23 | 2006-01-26 | Minghua Chen | Skin care composition |
JP2008507525A (en) * | 2004-07-23 | 2008-03-13 | ザ プロクター アンド ギャンブル カンパニー | Substrate-based skin care device |
MX2007000922A (en) * | 2004-07-23 | 2007-04-13 | Procter & Gamble | Skin care composition containing a flavonoid and vitamin b3. |
CN1988880A (en) * | 2004-07-23 | 2007-06-27 | 宝洁公司 | Skin care composition containing a flavonoid and vitamin b3 |
US20060034779A1 (en) * | 2004-08-02 | 2006-02-16 | Agis Industries (1983) Ltd. | Foamable compositions containing vitamin D3 analogues, processes for preparing same and methods of treatment utilizng same |
US20060057075A1 (en) * | 2004-08-02 | 2006-03-16 | Moshe Arkin | Pharmaceutical and cosmeceutical wash-off mousse shampoo compositions, processes for preparing the same and uses thereof |
US7704522B2 (en) * | 2004-09-08 | 2010-04-27 | Clyde Morgan | Topical medicament |
DK1809303T3 (en) * | 2004-09-23 | 2019-06-11 | Arc Medical Devices Inc | PHARMACEUTICAL COMPOSITION AND METHODS IN RELATION TO FIBROSE ADHESION OR INFLAMMATORIC DISEASE USING LOW SULPHATE FUCAN |
US7423064B2 (en) * | 2004-09-24 | 2008-09-09 | Olatec Industries, Llc | Composition for treating bacterial, viral, fungal diseases, inflammation and pain |
BRPI0517684A (en) * | 2004-11-09 | 2008-10-14 | Imaginative Res Associates Inc | retinoid solutions and formulations made from the same |
US7619008B2 (en) * | 2004-11-12 | 2009-11-17 | Kimberly-Clark Worldwide, Inc. | Xylitol for treatment of vaginal infections |
US20060106117A1 (en) * | 2004-11-12 | 2006-05-18 | Kimberly-Clark Worldwide, Inc. | Compound and method for prevention and/or treatment of vaginal infections |
WO2006058430A1 (en) * | 2004-12-02 | 2006-06-08 | Testa Hair Holdings Inc. | Composition for treating hair and scalp and method for preparing same |
EP1827371A2 (en) * | 2004-12-22 | 2007-09-05 | The Gillette Company | Reduction of hair growth |
CA2589875A1 (en) * | 2004-12-22 | 2006-06-29 | The Gillette Company | Reduction of hair growth |
KR20070086431A (en) * | 2004-12-22 | 2007-08-27 | 더 지렛트 캄파니 | Reduction of hair growth with survivin inhibitors |
US20060177392A1 (en) * | 2005-02-10 | 2006-08-10 | William Walden | Oil-based composition for acne |
US7390431B2 (en) * | 2005-03-10 | 2008-06-24 | Jr Chem, Llc | Stable organic peroxide compositions |
EP1898898A2 (en) * | 2005-03-10 | 2008-03-19 | Jr Chem, LLC | Benzoyl peroxide compositions and methods of use |
US20060223765A1 (en) * | 2005-03-30 | 2006-10-05 | Kimberly-Clark Worldwide, Inc. | Method for inhibiting and/or treating vaginal infection |
EP1709996A1 (en) * | 2005-04-07 | 2006-10-11 | L'oreal | Aqueous composition based on alcohol, surfactant and solubilizing agent, article impregnated with said composition and hair cleaning process |
AU2006245283B2 (en) * | 2005-05-10 | 2012-11-01 | Dermipsor Ltd. | Compositions and methods for treating hyperproliferative epidermal diseases |
CA2608021A1 (en) * | 2005-05-10 | 2006-11-16 | Dermipsor Ltd. | Compositions and methods for skin care |
WO2006125642A1 (en) | 2005-05-27 | 2006-11-30 | Antares Pharma Ipl Ag | Methods and apparatus for transdermal or transmucosal application of testosterone |
US7618956B2 (en) * | 2005-05-31 | 2009-11-17 | The Gillette Company | Reduction of hair growth |
PT2656860T (en) | 2005-06-17 | 2021-07-28 | Wisconsin Alumni Res Found | Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy |
WO2007005469A2 (en) * | 2005-06-29 | 2007-01-11 | Jr Chem, Llc | Method of enhanced benzoyl peroxide application |
WO2007005471A2 (en) * | 2005-06-29 | 2007-01-11 | Jr Chem, Llc | Stable organic peroxide compositions |
US20090306023A1 (en) * | 2005-06-29 | 2009-12-10 | Ramirez Jose E | Stable organic peroxide compositions |
WO2007002880A2 (en) * | 2005-06-29 | 2007-01-04 | Jr Chem, Llc | Method of enhanced drug application |
US7556820B2 (en) | 2005-06-29 | 2009-07-07 | Jr Chem, Llc | Stable organic peroxide compositions |
AR054805A1 (en) * | 2005-06-29 | 2007-07-18 | Stiefel Laboratories | TOPICAL COMPOSITIONS FOR SKIN TREATMENT |
US7560445B2 (en) | 2005-07-06 | 2009-07-14 | Taro Pharmaceuticals North America, Inc. | Process for preparing malathion for pharmaceutical use |
US7786176B2 (en) | 2005-07-29 | 2010-08-31 | Kimberly-Clark Worldwide, Inc. | Vaginal treatment composition containing xylitol |
JP5780690B2 (en) * | 2005-08-25 | 2015-09-16 | 大正製薬株式会社 | Hair growth composition |
US20070071705A1 (en) * | 2005-09-29 | 2007-03-29 | De Oliveira Monica A M | Topical anti-microbial compositions |
JP5584415B2 (en) | 2005-10-12 | 2014-09-03 | ユニメッド・ファーマシューティカルズ・エルエルシー | Improved testosterone gel formulation and method of use |
FR2892930B1 (en) * | 2005-11-09 | 2012-03-09 | Oreal | COSMETIC COMPOSITION COMPRISING A STRUCTURING SILICONE POLYMER OF A FATTY PHASE CHARACTERIZED BY VISCOSITY |
FR2892929B1 (en) * | 2005-11-09 | 2012-04-27 | Oreal | COSMETIC COMPOSITION COMPRISING A FATTY-STRUCTURING SILICONE POLYMER CHARACTERIZED BY HARDNESS |
US8147815B2 (en) * | 2005-12-16 | 2012-04-03 | Celmatrix Corporation | Topical administration carrier composition and therapeutic formulations comprising same |
WO2007092312A2 (en) * | 2006-02-03 | 2007-08-16 | Stiefel Laboratories, Inc. | Topical skin treating compositions |
EP1998742A2 (en) * | 2006-03-08 | 2008-12-10 | Nuviance, INC. | Transdermal drug delivery compositions and topical compositions for application on the skin |
EP2206494B1 (en) | 2006-03-31 | 2015-12-02 | Stiefel Research Australia Pty Ltd | Foamable suspension gel |
US8399012B2 (en) | 2006-04-17 | 2013-03-19 | Kimberly-Clark Worldwide, Inc. | Degradable therapeutic delivery device |
NZ571460A (en) | 2006-04-21 | 2010-10-29 | Antares Pharma Ipl Ag | Methods of treating hot flashes with formulations for transdermal or transmucosal application |
US8703179B2 (en) * | 2006-05-11 | 2014-04-22 | Kimberly-Clark Worldwide, Inc. | Mucosal formulation |
EP2026753B1 (en) | 2006-05-19 | 2012-04-11 | Mary Kay, Inc. | Compositions comprising glyceryl salicylate compounds |
US20080008759A1 (en) * | 2006-05-30 | 2008-01-10 | Den-Mat Corporation | Method of improving wound healing |
ATE457729T1 (en) * | 2006-06-01 | 2010-03-15 | Nobera Pharma Sl | USE OF ALLOPURINOL FOR THE TREATMENT OF PALMAR/PLANTAR ERYTHRODYSAESTHESIA |
US20080059313A1 (en) * | 2006-08-30 | 2008-03-06 | Oblong John E | Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair |
US20080099168A1 (en) * | 2006-10-26 | 2008-05-01 | Kou-Chang Liu | Soft and absorbent tissue products |
WO2008082525A1 (en) * | 2006-12-19 | 2008-07-10 | National Stem Cell Inc | Umbilical cord stem cell secreted product derived topical compositions and methods of use thereof |
WO2008109182A1 (en) * | 2007-03-07 | 2008-09-12 | Grune Guerry L | Sunblock formulations |
US20080241085A1 (en) | 2007-03-29 | 2008-10-02 | Lin Connie B | Compositions for use in darkening the skin |
FR2915097B1 (en) * | 2007-04-18 | 2012-09-28 | Fabre Pierre Dermo Cosmetique | ANTIFUNGAL FOAM BASED ON CICLOPIROXOLAMINE AND ZINC PYRITHIONE AND ITS MEDICAL AND COSMETIC APPLICATIONS. |
KR101527829B1 (en) | 2007-04-19 | 2015-06-12 | 마리 케이 인코포레이티드 | Magnolia extract containing compositions |
JP2010524648A (en) * | 2007-04-23 | 2010-07-22 | トランスダーマル キャップ インコーポレイテッド | Phototherapy light cap |
EP2152242A1 (en) * | 2007-05-21 | 2010-02-17 | Sergeant's Pet Care Products | Pest control formulation |
HU227970B1 (en) | 2007-07-10 | 2012-07-30 | Egis Gyogyszergyar Nyrt | Pharmaceutical compositions containing silicones of high volatility |
WO2009032907A2 (en) * | 2007-09-04 | 2009-03-12 | Quinnova Pharmaceuticals, Inc. | Stay-on selenium foam |
US20090087395A1 (en) | 2007-10-01 | 2009-04-02 | Lin Connie B | Compositions for use in darkening the skin |
MX2010003894A (en) * | 2007-10-11 | 2010-04-30 | Mcneil Ppc Inc | Improved topical pain relief product. |
BRPI0911392A2 (en) * | 2008-04-21 | 2015-12-29 | Mcneil Ppc Inc | dual aerosol tube topical dispensing device |
US8729108B2 (en) * | 2008-06-17 | 2014-05-20 | Christopher J Dannaker | Waterborne topical compositions for the delivery of active ingredients such as azelaic acid |
RU2018129725A (en) * | 2008-07-18 | 2019-03-20 | Байомод Консептс Инк. | PRODUCTS RELEASING THE ACTIVE INGREDIENT |
US9750812B2 (en) * | 2008-09-27 | 2017-09-05 | Jina Pharmaceuticals, Inc. | Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof |
BRPI0914454A2 (en) * | 2008-10-21 | 2015-10-27 | Novodermix Internat Ltd | "composition for the treatment of epithelial tissue" |
US20100209368A1 (en) * | 2009-02-11 | 2010-08-19 | Walsh Joseph F | Method and preparation for treating baldness |
US20150374600A1 (en) * | 2009-02-11 | 2015-12-31 | Joseph F. Walsh | Methods and preparations that treat human hair loss |
US20100242155A1 (en) * | 2009-03-25 | 2010-09-30 | Carullo Jr John F | Headgear equipped with laser hair care apparatus |
WO2010121919A1 (en) * | 2009-04-23 | 2010-10-28 | Unilever Plc | Hair care composition comprising trichogen complex and an azole |
EA027251B1 (en) | 2009-04-23 | 2017-07-31 | Унилевер Н.В. | Composition comprising azole fungicide and water soluble metal salt |
EP2246057A1 (en) * | 2009-04-29 | 2010-11-03 | Nobera Pharma, S.L. | Use of allopurinol for the treatment of hand foot skin reaction |
US8470304B2 (en) | 2009-08-04 | 2013-06-25 | Avidas Pharmaceuticals Llc | Therapeutic vitamin D sun-protecting formulations and methods for their use |
ES2637447T3 (en) | 2009-08-31 | 2017-10-13 | Dr. Reddy's Laboratories Ltd. | Topical formulations containing a steroid |
US20110076312A1 (en) * | 2009-09-29 | 2011-03-31 | Ethicon, Inc. | Antimicrobial/antibacterial medical devices coated with traditional chinese medicines |
US8470833B2 (en) * | 2009-12-15 | 2013-06-25 | Mcneil-Ppc, Inc. | Hair growth and/or regrowth compositions |
US8470880B2 (en) * | 2009-12-15 | 2013-06-25 | Mcneil-Ppc, Inc. | Methods of reducing hair loss and/or facilitating hair growth and/or regrowth |
US20120003300A1 (en) * | 2010-06-30 | 2012-01-05 | Pangaea Laboratories Ltd | Composition Comprising Vascular Endothelial Growth Factor (VEGF) for the Treatment of Hair Loss |
US20120064135A1 (en) * | 2010-09-15 | 2012-03-15 | Norac Pharma | Benzoyl Peroxide Composition, Methods for Making Same, and Pharmaceutical or Cosmetic Formulations Comprising Same, and Uses Thereof |
EP2438908A1 (en) | 2010-10-11 | 2012-04-11 | Vectum Pharma, S.L. | Anchoring compositions for topical applications |
US20120128753A1 (en) * | 2010-11-18 | 2012-05-24 | Sally Villalobos | Meditowel pre-packaged medicated muscle and joint pain relief wipe |
CN103442702B (en) * | 2011-01-07 | 2016-02-10 | 阿勒根公司 | Melanin improved composition and using method thereof |
EP2702982B1 (en) * | 2011-04-25 | 2016-12-14 | Jun-Hyoung Park | Composition for topical application for preventing hair loss and stimulating hair growth |
CN103857440B (en) | 2011-06-22 | 2018-09-25 | 维奥姆生物科学有限公司 | Antimycotic and antibacterium prodrug based on conjugate |
FR2992859B1 (en) * | 2012-07-09 | 2014-10-03 | Fabre Pierre Dermo Cosmetique | USE OF COCETH ZINC SULFATE AS ANTIBACTERIAL AGENT AFTER PROPIONIBACTERIUM ACNES |
US11154535B2 (en) | 2012-07-31 | 2021-10-26 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
US10045935B2 (en) | 2012-07-31 | 2018-08-14 | Egis Pharmaceuticals Plc | Transdermal formulation containing COX inhibitors |
BR102012022036B1 (en) * | 2012-08-31 | 2019-10-01 | Biolab Sanus Farmacêutica Ltda. | FINASTERIDE AND MINOXIDIL POLYMERIC NANOParticle, PROCESS OF PREPARATION, WATER-CONTAINING SUSPENSION, PHARMACEUTICAL COMPOSITION, AND ITS USE |
US8697753B1 (en) | 2013-02-07 | 2014-04-15 | Polichem Sa | Method of treating onychomycosis |
CN105142400B (en) | 2013-03-12 | 2018-02-13 | 玫琳凯有限公司 | Protective system |
TWI522102B (en) | 2013-04-30 | 2016-02-21 | 長庚醫療財團法人 | Use of composition for manufacturing drugs for treating or prophylactically treating acne |
WO2014184173A1 (en) * | 2013-05-14 | 2014-11-20 | Montero Gida Sanayi Ve Ticaret A.S. | Hair care formulations |
BR112015030501A2 (en) | 2013-06-04 | 2017-07-25 | Vyome Biosciences Pvt Ltd | coated particles and compositions comprising them |
US9011934B2 (en) * | 2013-06-14 | 2015-04-21 | SatisPharma, LLC | Multi-purpose anti-itch treatment |
EP2829303A1 (en) * | 2013-07-22 | 2015-01-28 | Johnson & Johnson Consumer Companies Inc. | Compositions comprising extract of malva neglecta and method of treating a skin condition with malva neglecta |
EP3041455A1 (en) | 2013-09-05 | 2016-07-13 | The Procter and Gamble Company | Scalp care composition |
CN105813627A (en) | 2013-12-13 | 2016-07-27 | 雷斯托尔西有限公司 | Exfoliative hair retention-promoting formulation |
US9522189B2 (en) | 2013-12-20 | 2016-12-20 | Johnson & Johnson Consumer Inc. | Topical gel compositions including poly(monostearoyl glycerol-co-succinate) polymer and methods for enhancing the topical application of a benefit agent |
US20150174254A1 (en) * | 2013-12-23 | 2015-06-25 | Mcneil-Ppc, Inc. | Topical gel compositions including polycaprolactone polymer and methods for enhancing the topical application of a benefit agent |
US20160184431A1 (en) | 2014-03-11 | 2016-06-30 | Promius Pharma Llc | Topical compositions comprising a corticosteroid |
US9468606B2 (en) | 2014-03-31 | 2016-10-18 | Johnson & Johnson Consumer Inc. | Compostions and methods for enhancing the topical application of an acidic benefit agent |
US9474699B2 (en) | 2014-03-31 | 2016-10-25 | Johnson & Johnson Consumer Inc. | Compostions and methods for enhancing the topical application of a basic benefit agent |
MX2016013894A (en) | 2014-04-24 | 2017-02-02 | Procter & Gamble | Scalp care composition. |
AU2015259509A1 (en) | 2014-05-16 | 2016-11-24 | Restorsea, Llc | Biphasic cosmetic |
US11696883B2 (en) | 2014-05-23 | 2023-07-11 | Triple Hair Inc. | Compositions for reducing hair loss and/or increasing hair regrowth |
EP3062797B1 (en) * | 2014-05-23 | 2019-08-28 | Triple Hair Inc. | Compositions for reducing hair loss and/or increasing hair regrowth |
RU2017101050A (en) | 2014-06-16 | 2018-07-16 | Джонсон энд Джонсон Консьюмер Инк. | COMPOSITIONS AND METHODS FOR IMPROVING EFFECTIVENESS OF LOCAL APPLICATION OF COLORED COSMETIC PRODUCT |
WO2015195304A1 (en) | 2014-06-17 | 2015-12-23 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for enhancing the topical application of a benefit agent including powder to liquid particles and a second powder |
US9675537B2 (en) | 2014-06-30 | 2017-06-13 | Johnson & Johnson Consumer Inc. | Hair growth composition and method |
US9452178B1 (en) | 2014-10-22 | 2016-09-27 | SatisPharma, LLC | Acne formulations, treatments, and pressure sensitive patches for delivery of acne formulations |
IL251862B2 (en) * | 2014-10-24 | 2023-09-01 | Beautopia Llc | Combined hair loss inhibition treatment |
WO2016105499A1 (en) | 2014-12-23 | 2016-06-30 | Intellectual Property Associates, Llc | Methods and formulations for transdermal administration |
US9351945B1 (en) | 2015-02-27 | 2016-05-31 | John Daniel Dobak, III | Reduction of adipose tissue |
EP3347009B1 (en) | 2015-07-08 | 2021-10-13 | Triple Hair Inc. | Composition comprising resveratrol and melatonin for reducing hair loss and/or increasing hair regrowth |
US10130578B2 (en) | 2015-07-23 | 2018-11-20 | Johnson & Johnson Consumer Inc. | Topical delivery of skin compositions having low pH |
JP2018528839A (en) | 2015-09-22 | 2018-10-04 | ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッドJohnson & Johnson Consumer Inc. | Methods for enhancing topical application of benefit agents |
JP2017078044A (en) * | 2015-10-21 | 2017-04-27 | 大正製薬株式会社 | Hair Restorer Composition |
US11666520B2 (en) * | 2015-12-28 | 2023-06-06 | Johnson & Johnson Consumer Inc. | Hair growth composition and method |
US9962444B2 (en) | 2016-09-27 | 2018-05-08 | Shane Malek | Pharmacokinetically extended action topical hair growth formulation, and administration method |
PL3558211T3 (en) | 2016-12-23 | 2023-10-02 | R.P. Scherer Technologies, Llc | Multiple-fill/chamber softgel die |
WO2018206077A1 (en) * | 2017-05-08 | 2018-11-15 | Merz Pharma Gmbh & Co. Kgaa | Emulsion comprising finasteride |
CN107281185B (en) * | 2017-06-16 | 2018-08-17 | 曹凡 | A kind of trichogenous emulsification composition and preparation method thereof |
EP3418365A1 (en) | 2017-06-19 | 2018-12-26 | The Procter & Gamble Company | Automatic dishwashing cleaning composition |
WO2019070142A2 (en) * | 2017-10-08 | 2019-04-11 | Qatar Pharma For Pharmaceuticals Industries | Topical lotion for hair loss treatment (biohair®) |
WO2019096635A1 (en) * | 2017-11-16 | 2019-05-23 | Dsm Ip Assets B.V. | Topical compositions |
JP2019210268A (en) * | 2018-05-30 | 2019-12-12 | ダイヤ製薬株式会社 | External preparation and method for producing external preparation |
CN110604741A (en) * | 2018-06-15 | 2019-12-24 | 瑞恩生化科技有限公司 | Composition for inhibiting skin cell proliferation and application thereof |
CN108743422A (en) * | 2018-06-27 | 2018-11-06 | 天津静瀛高新科技有限公司 | Broad-spectrum sterilization type shampoo and its manufacturing method |
US10463596B1 (en) | 2018-06-28 | 2019-11-05 | The Procter And Gamble Company | Scalp care composition with well dispersed particulate scalp benefit agents |
WO2022125405A1 (en) | 2020-12-07 | 2022-06-16 | O&M Halyard, Inc. | Damp hand donning and moisturizing glove |
CN115475168B (en) * | 2022-10-18 | 2024-02-13 | 湖北工业大学 | Minoxidil-containing pharmaceutical composition and preparation method and application thereof |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4139619A (en) | 1976-05-24 | 1979-02-13 | The Upjohn Company | 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth |
US4596812A (en) | 1976-05-24 | 1986-06-24 | The Upjohn Company | Methods and solutions for treating male pattern alopecia |
WO1988001863A1 (en) | 1986-09-12 | 1988-03-24 | The Upjohn Company | Foams for delivery of minoxidil |
JPH03236317A (en) * | 1989-12-06 | 1991-10-22 | Sansei Seiyaku Kk | Dopamine derivative-containing percutaneous |
WO1992003123A1 (en) * | 1990-08-28 | 1992-03-05 | Liposome Technology, Inc. | Liposome alternative bilayer formulations |
US5152997A (en) | 1990-12-11 | 1992-10-06 | Theratech, Inc. | Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels |
JPH069394A (en) * | 1992-06-25 | 1994-01-18 | Lion Corp | External antiphlogistic sedative liquid preparation |
DE4330597A1 (en) | 1992-10-14 | 1995-03-16 | Ahmad Khalil | Hair tonic system and hair lotion for hair loss |
WO1994021262A1 (en) | 1993-03-17 | 1994-09-29 | Alza Corporation | Device for the transdermal administration of alprazolam |
JPH072677A (en) | 1993-06-18 | 1995-01-06 | Toyo Seito Kk | Peroral hair-growing agent |
JP3520936B2 (en) * | 1993-12-07 | 2004-04-19 | 大正製薬株式会社 | Hair restorer |
JPH07233088A (en) * | 1993-12-27 | 1995-09-05 | Takeda Chem Ind Ltd | External agent for topical application |
US5629021A (en) * | 1995-01-31 | 1997-05-13 | Novavax, Inc. | Micellar nanoparticles |
US5945409A (en) * | 1995-03-10 | 1999-08-31 | Wilson T. Crandall | Topical moisturizing composition and method |
JPH0948740A (en) * | 1995-08-04 | 1997-02-18 | Pola Chem Ind Inc | Selective medicine absorption promoter |
JPH0971513A (en) | 1995-09-07 | 1997-03-18 | Taisho Pharmaceut Co Ltd | Hair tonic |
JPH0987148A (en) * | 1995-09-21 | 1997-03-31 | Suntory Ltd | Hair growing composition |
JPH09268123A (en) * | 1996-03-30 | 1997-10-14 | Nichiban Co Ltd | Cataplasm for local anesthesia |
JPH09278651A (en) * | 1996-04-05 | 1997-10-28 | Sekisui Chem Co Ltd | Percutaneous strap |
US5837289A (en) * | 1996-07-23 | 1998-11-17 | Grasela; John C. | Transdermal delivery of medications using a combination of penetration enhancers |
-
1999
- 1999-07-23 US US09/360,412 patent/US6284234B1/en not_active Expired - Lifetime
- 1999-08-02 JP JP2000563309A patent/JP2003521452A/en active Pending
- 1999-08-02 AU AU56695/99A patent/AU5669599A/en not_active Abandoned
- 1999-08-02 WO PCT/US1999/017387 patent/WO2000007627A2/en not_active Application Discontinuation
- 1999-08-02 EP EP99943639A patent/EP1104280A2/en not_active Withdrawn
- 1999-08-02 CN CN99806702A patent/CN1303263A/en active Pending
- 1999-08-02 CA CA002339231A patent/CA2339231A1/en not_active Abandoned
- 1999-08-03 AR ARP990103865A patent/AR019997A1/en unknown
- 1999-08-04 CO CO99049352A patent/CO5080786A1/en unknown
- 1999-08-18 TW TW088113282A patent/TWI257310B/en not_active IP Right Cessation
-
2001
- 2001-07-26 US US09/916,019 patent/US6419913B1/en not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE43372E1 (en) | 1999-03-05 | 2012-05-08 | Duke University | C16 unsaturated FP-selective prostaglandins analogs |
US8906962B2 (en) | 2000-03-31 | 2014-12-09 | Duke University | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
US9346837B2 (en) | 2000-03-31 | 2016-05-24 | Duke University | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
US9579270B2 (en) | 2000-03-31 | 2017-02-28 | Duke University | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
US9006291B2 (en) | 2009-02-03 | 2015-04-14 | Pharma Patent Holding Inc. | Composition, method and kit for enhancing hair |
Also Published As
Publication number | Publication date |
---|---|
WO2000007627A2 (en) | 2000-02-17 |
US20020048558A1 (en) | 2002-04-25 |
JP2003521452A (en) | 2003-07-15 |
CA2339231A1 (en) | 2000-02-17 |
AR019997A1 (en) | 2002-03-27 |
CO5080786A1 (en) | 2001-09-25 |
CN1303263A (en) | 2001-07-11 |
WO2000007627A3 (en) | 2000-08-17 |
US6284234B1 (en) | 2001-09-04 |
US6419913B1 (en) | 2002-07-16 |
TWI257310B (en) | 2006-07-01 |
AU5669599A (en) | 2000-02-28 |
EP1104280A2 (en) | 2001-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000007627A8 (en) | Topical delivery systems for active agents | |
EP1060732A3 (en) | Novel topical formulations comprising vesicle delivery systems | |
DK0841899T3 (en) | Preparations for topical administration of active ingredients | |
EP0863740B1 (en) | Reduction of hair growth | |
NZ511773A (en) | Compositions and methods for treating hair and skin using aqueous delivery systems | |
EP0934742A3 (en) | High glycerin containing anti-microbial cleansers | |
ES2160631T3 (en) | RETINOID COMPOSITIONS FOR TOPICAL APPLICATION. | |
AU3956599A (en) | Surfactant for use in external preparations for skin and external preparation for skin containing the same | |
CA2137001A1 (en) | Lipids for Epidermal Moisturization and Repair of Barrier Function | |
RU94045127A (en) | Depigmentation composition and method for depigmentation of skin | |
BR9915008A (en) | Shampoo composition, and process for preparing it | |
EP1004289A3 (en) | Cosmetic and skin protective compositions comprising catalase | |
EP1190696A3 (en) | Hair cosmetic compositions and use thereof | |
EP1374831A4 (en) | Cosmetics or external preparations for skin | |
MX2007014754A (en) | Composition comprising resveratrol and topical use thereof for reducing human hair growth. | |
WO2003086331A3 (en) | Reduction of hair growth | |
AU3931093A (en) | Topical composition for inhibiting hair growth | |
BR0013968B1 (en) | structuring product composition for personal care formulations. | |
WO2005032498A3 (en) | Aqueous composition comprising a polyionic dendritic polymer and an ionic surface active agent | |
AUPR874601A0 (en) | Selective targeting of apoptotic cells | |
EP1192939A3 (en) | Methods for reduction of inflammation and erythema | |
WO1999013819A3 (en) | Composition and method for reducing stinging in skin | |
MX2021015830A (en) | Transdermal penetrant formulations. | |
US6843983B2 (en) | Shaving preparations and methods for the prevention and treatment of pseudofolliculitis barbae | |
US6528072B1 (en) | Topical composition for skin including witch hazel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99806702.4 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref document number: 2339231 Country of ref document: CA Ref document number: 2339231 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999943639 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i |
Free format text: PAT. BUL. 07/2000 UNDER (30) REPLACE "09/363412" BY "09/360412" |
|
WWP | Wipo information: published in national office |
Ref document number: 1999943639 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999943639 Country of ref document: EP |